BUSINESS
By Liz Bowie and Liz Bowie,Staff Writer | April 24, 1992
Officials at the National Institutes of Health said yesterday that a new whooping cough vaccine made by North American Vaccine Inc. of Beltsville appears to be safe.The results take the company one step closer to being able to market the product."We think this is an enormous improvement," said Dr. Charles Lowe, associate director for special projects at the National Institute of Child Health and Human Development.The federal government is interested in finding a substitute for the vaccine now used to fight pertussis, a highly infectious childhood disease also known as whooping cough.
BUSINESS
By BLOOMBERG BUSINESS NEWS | October 30, 1996
BETHESDA -- North American Vaccine's new whooping cough vaccine received a mixed reception from a governmental advisory panel yesterday. Experts said they think it's safe and effective, yet don't know how effective."
NEWS
By Jonathan Bor and Jonathan Bor,Staff Writer | November 22, 1993
Cases of whooping cough, once among the most feared of all childhood diseases, are climbing in Maryland and elsewhere partly because of parents' complacency.Although public health authorities do not foresee epidemics approaching the huge ones of old, doctors say many infants and young children are needlessly at risk because they are slow to get their full complement of shots."The majority of the children who are getting this disease and are being hospitalized are inadequately immunized," said Dr. Neal A. Halsey, a specialist in pediatric infections at Johns Hopkins Hospital.
NEWS
By Erika Niedowski and Jonathan Bor and Erika Niedowski and Jonathan Bor,SUN STAFF | March 18, 2005
It started out much like any winter cold. But, soon enough, 16-year-old Zachary Graham couldn't stop coughing. And coughing. When doctors finally diagnosed Zach a few weeks later, they told him that his hacking fits - which sometimes made it hard to breathe and sleep - were caused by a disease the teenager thought he couldn't get: whooping cough. "When I was diagnosed, my parents and I were surprised that I had it because I had been vaccinated against the disease," said Graham, a high school junior from Sunapee, N.H., whose illness kept him off the ski slopes and away from his friends.
BUSINESS
By Mark Guidera and Mark Guidera,SUN STAFF | July 31, 1998
North American Vaccine Inc. yesterday won a long-awaited Food and Drug Administration approval to market its new whooping cough vaccine for children in the United States.The approval, which took the Beltsville-based company almost two years to land, marks the first U.S. product approval for the 12-year-old biotechnology company."This is really big for us," said Stephen M. Keith, vice president for sales and marketing for North American. "Clearly, the U.S. is a big market, and we're confident the vaccine will do well gaining market share."
BUSINESS
By Mark Guidera and Mark Guidera,SUN STAFF | February 9, 1996
A Maryland company has won marketing approval in Sweden for a new, powerful vaccine to protect children against whooping cough and, as a result, now has an edge in the race to grab a share of the estimated $800 million U.S. and European market for the new-generation vaccines.North American Vaccine, based in Beltsville, won approval yesterday to market its vaccine for whooping cough, the dreaded disease also known as pertussis.On news of the approval, the company's stock rose $1.125 per share to $15.50, a 12-month high.